Atlas Trials

Rigel Pharmaceuticals

28 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Rigel Pharmaceuticals

RecordFirmDate
Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors (NCT07704658)Rigel Pharmaceuticals2026-03-04
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies (NCT07486713)Rigel Pharmaceuticals2026-02-23
Study of Olutasidenib and Temozolomide in HGG (NCT06161974)Rigel Pharmaceuticals2025-02-01
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS) (NCT05308264)Rigel Pharmaceuticals2022-09-12
Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy (NCT04904276)Rigel Pharmaceuticals2021-05-18
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects (NCT04629703)Rigel Pharmaceuticals2021-03-25
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA (NCT03764618)Rigel Pharmaceuticals2019-04-24

Track Rigel Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.